M&T BANK CORP - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 82 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q2 2020$149,000
+140.3%
13,3330.0%0.00%
Q1 2020$62,000
+8.8%
13,3330.0%0.00%
Q4 2019$57,000
+9.6%
13,3330.0%0.00%
Q3 2019$52,000
-1.9%
13,3330.0%0.00%
Q2 2019$53,000
-8.6%
13,3330.0%0.00%
Q1 2019$58,000
+23.4%
13,3330.0%0.00%
Q4 2018$47,000
-7.8%
13,3330.0%0.00%
Q3 2018$51,000
-1.9%
13,3330.0%0.00%
Q2 2018$52,000
+23.8%
13,3330.0%0.00%
Q1 2018$42,000
-19.2%
13,3330.0%0.00%
Q4 2017$52,000
-5.5%
13,3330.0%0.00%
Q3 2017$55,0000.0%13,3330.0%0.00%
Q2 2017$55,000
-3.5%
13,3330.0%0.00%
Q1 2017$57,000
+67.6%
13,3330.0%0.00%
Q4 2016$34,000
+6.2%
13,3330.0%0.00%
Q3 2016$32,0000.0%13,3330.0%0.00%
Q2 2016$32,000
-11.1%
13,3330.0%0.00%
Q1 2016$36,000
-5.3%
13,3330.0%0.00%
Q4 2015$38,000
+22.6%
13,3330.0%0.00%
Q3 2015$31,000
-35.4%
13,3330.0%0.00%
Q2 2015$48,000
-53.8%
13,333
-42.9%
0.00%
-100.0%
Q1 2015$104,000
-6.3%
23,3330.0%0.00%0.0%
Q4 2014$111,00023,3330.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q2 2020
NameSharesValueWeighting ↓
ABNER HERRMAN & BROCK LLC 239,000$2,679,0000.48%
EAM Investors, LLC 81,854$918,0000.20%
CFO4Life Group, LLC 12,003$135,0000.05%
Phoenix Holdings Ltd. 104,782$1,112,0000.05%
WINTON GROUP Ltd 118,487$1,328,0000.03%
Merit Financial Group, LLC 28,731$322,0000.03%
HighPoint Advisor Group LLC 13,533$151,0000.03%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 23,000$258,0000.02%
ETF MANAGERS GROUP, LLC 52,216$579,0000.02%
IHT Wealth Management, LLC 13,000$146,0000.02%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders